Treatment challenges and delivery systems in immunomodulation and probiotic therapies for periodontitis

Anže Zidar,Julijana Kristl,Petra Kocbek,Špela Zupančič
DOI: https://doi.org/10.1080/17425247.2021.1908260
2021-05-09
Expert Opinion on Drug Delivery
Abstract:<span><b>Introduction</b>: Periodontitis is a widespread illness that arises due to disrupted interplay between the oral microbiota and the host immune response. In some cases, conventional therapies can provide temporary remission, although this is often followed by disease relapse. Recent studies of periodontitis pathology have promoted the development of new therapeutics to improve treatment options, together with local application using advanced drug delivery systems.<b>Areas covered</b>: This paper provides a critical review of the status of current treatment approaches to periodontitis, with a focus on promising immunomodulation and probiotic therapies. These are based on delivery of small molecules, peptides, proteins, DNA or RNA, and probiotics. The key findings on novel treatment strategies and formulation of advanced delivery systems, such as nanoparticles and nanofibers, are highlighted.<b>Expert opinion</b>: Multitarget therapy based on antimicrobial, immunomodulatory, and probiotic active ingredients incorporated into advanced delivery systems for application to the periodontal pocket can improve periodontitis treatment outcomes. Translation of such adjuvant therapy from laboratory to patient is expected in the future.</span>
pharmacology & pharmacy
What problem does this paper attempt to address?